Brice Dubois is an expert in Oncology at Centre François Baclesse (France). Brice Dubois has authored 6 publications, the most recent in 2025. SLR score: 7 (community average: 125). How the SLR is computed.

LeadR Profile

Brice Dubois Centre François Baclesse France
7 ScienceLeadR Reputation 7
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2023 - 2025

Source: PubMed

Centre François Baclesse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 6

Citations

Citations: 71 1st author: 0 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.
PMID 39934735 — poly(adp-ribose) polymerase inhibitors, neoplasms, predictive value of tests, drug therapy, organoids, therapeutics, endometrial neoplasms, chemotherapy
BMC Cancer20251
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
PMID 37726786 — triple negative breast neoplasms, therapeutics, precision medicine, organoids
BMC Cancer20238
ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
PMID 36894916 — cells, carcinoma, squamous cell, neoplasms, squamous cell carcinoma of head and neck, organoids, therapeutics
BMC Cancer202315
Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.
PMID 23008303 — regression analysis, parenting, hodgkin disease, lymphoma, case-control studies, aftercare, population control, therapeutics, child
J Clin Oncol201210
Evaluation of current practice: management of chemotherapy-related toxicities.
PMID 21795972 — creatinine, antineoplastic agents, drug therapy, practice management, risk factors, chemotherapy
Anticancer Drugs201118

LeadR Networks

Main global connection map